Waltham, MA, June 24, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, announces the pharma industry’s first and only benchmarking-based launch planning offering. The Trinity Launch Planning Solution is deeply rooted in real drug launch experience to empower superior commercialization readiness.
Through proprietary technology, Trinity launch experts can quickly pull best practices from past effective launches of treatments in a specific therapeutic area based on unique benchmarking data. This allows Trinity to start with a solid…
Read Now
Waltham, MA, June 16, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, introduces a new turnkey stakeholder insight research tool that evaluates the impact of COVID-19 on patient management and load, prescribing and compliance behaviors and sales detailing relative to pre-COVID times. COVIDPulse helps pharma companies understand how the pandemic has impacted their base business, how telemedicine has changed the landscape and what change (if any) there has been on utilization of a specific product or…
Read Now
Waltham, MA, June 4,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, finds that New Product Planning
(NPP) pharmaceutical executives are uncertain about how COVID-19 will affect
the volume of business development efforts. According to the new brief entitled
Impact of COVID-19 on New Product Planning, NPP teams are mixed in their
expectations for the volume of business development (BD) efforts to change in
the near term due to the COVID-19 outbreak.
“NPP teams are seeking…
Read Now
Waltham, MA, May 27,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, found that the majority of in-depth
discussions at last week’s virtual TGaS Spring Summit focused on how pharmaceutical
companies’ commercial operations need to adjust in response to the current
pandemic. COVID-19-related topics that were addressed by the 337 pharmaceutical
executives included:
Implications of delayed clinical trialsNext steps for field force re-entry (state and
local guidelines, obtaining appropriate quantities of personal protective
equipment (PPE), planning…
Read Now
Waltham, MA, May 19,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, is sharing findings from its latest
TGaS Landscape report entitled, “Launch Excellence Advisory Study.” The report
is based on interviews of 30 biopharmaceutical company Chief Commercial
Officers who shared their experience on the type of drug launch preparation
necessary to ensure success.
One of the major take-aways was that pharmaceutical
companies with “too much budget” were less likely to have high performing launches.
Of…
Read Now
Waltham, Mass., May 6,
2020 — Trinity Life Sciences,
a leader in global life sciences commercialization solutions, announced the
availability of its 2019 Trinity Drug
Index, a commercial analysis of 26 unique therapeutic agents approved in
2016. The Index shows several new trends in drug approvals and evaluates actual
commercial performance of novel drugs post-approval.
The Trinity Drug Index outlines key themes and emerging
trends in the industry as more targeted and innovative products emerge. Scoring
is based on a…
Read Now
Waltham, MA, April 28, 2020 — Trinity Life Sciences, a leader in global
life sciences solutions, announced today the availability of a new TGaS
benchmarking assessment that identifies the high-risk functions within pharma
that are least prepared for challenges generated by the COVID-19 pandemic.
Sales rep
training, forecasting, competitive intelligence, patient support services and
KOL relationship management are among the highest risk functions that need to
consider significant evolution to adjust to a current and post-pandemic world.
“The
COVID-19 crisis…
Read Now
Waltham, MA, April 22, 2020 — Trinity Life Sciences, a leader in global
life sciences solutions, announced today the availability of a new brief
regarding the impact of COVID-19 on telehealth.
The brief, based on a survey of 561 healthcare providers
(HCPs) in the U.S., finds that 46 percent of healthcare providers across a wide
range of specialties are using more telemedicine than before COVID-19.
Radiologists, psychiatrists and cardiologists are leading the charge in
providing telemedicine, but many other specialties…
Read Now
Waltham, MA, April 14,
2020 – Trinity Life Sciences, a global leader in life sciences solutions,
today announced it has named Peter Hoenigsberg to its Board of Directors. Mr.
Hoenigsberg’s CEO and private equity experience brings a valuable level of
business knowledge and perspective to the Board.
Mr. Hoenigsberg most recently was a senior advisor for
Providence Equity Partners helping build their information services portfolio.
Prior to joining Providence, he was CEO of Decision Resources Group (DRG), a highly
successful…
Read Now
Waltham, MA, April 9, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, and Toluna, a leading consumer intelligence platform that delivers insights on demand, announced today the availability of a new brief regarding the impact of COVID-19 on healthcare market research.
The co-sponsored brief, based on a survey of approximately 560 healthcare providers in the U.S., finds that physicians in private practices or community settings have an increased availability to participate in research. This increase in…
Read Now
